In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Plus Therapeutics Inc (NASDAQ: PSTV) was $1.43 for the day, up 12.60% from the previous closing price of $1.27. In other words, the price has increased by $12.60 from its previous closing price. On the day, 23.48 million shares were traded.
Ratios:
Our analysis of PSTV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on January 25, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
On October 16, 2020, Maxim Group started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 13 ’24 when Hawkins Richard J bought 4,000 shares for $1.50 per share. The transaction valued at 5,996 led to the insider holds 15,188 shares of the business.
Hawkins Richard J bought 6,285 shares of PSTV for $8,512 on Sep 12 ’24. The Director now owns 11,188 shares after completing the transaction at $1.35 per share. On Sep 11 ’24, another insider, Petersen Greg, who serves as the Director of the company, bought 12,500 shares for $1.35 each. As a result, the insider paid 16,875 and bolstered with 48,921 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47.
Stock Price History:
Over the past 52 weeks, PSTV has reached a high of $2.67, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 25.17%, while the 200-Day Moving Average is calculated to be -0.95%.
Shares Statistics:
A total of 5.90M shares are outstanding, with a floating share count of 5.75M. Insiders hold about 2.55% of the company’s shares, while institutions hold 11.50% stake in the company.
Earnings Estimates
The stock of Plus Therapeutics Inc (PSTV) is currently in the spotlight, with 4.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.33 and low estimates of -$0.78.
Analysts are recommending an EPS of between -$1.94 and -$2.21 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$2.1, with 4.0 analysts recommending between -$1.55 and -$3.56.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $1.73M. There is a high estimate of $1.9M for the next quarter, whereas the lowest estimate is $1.5M.
A total of 3 analysts have provided revenue estimates for PSTV’s current fiscal year. The highest revenue estimate was $6.23M, while the lowest revenue estimate was $4.41M, resulting in an average revenue estimate of $5.41M. In the same quarter a year ago, actual revenue was $4.91M
